DENALI ADVISORS LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$3,546,000
-12.4%
225,600
-8.4%
0.53%
-17.9%
Q1 2018$4,050,000
-17.8%
246,200
-9.8%
0.65%
-15.2%
Q4 2017$4,930,000273,0000.76%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders